CVS Health Corp.'s stock rose 1.7% Monday after a report surfaced of a meeting between the healthcare company and its major hedge-fund investor, Glenview Capital Management. CVS also confirmed plans to reduce its workforce by 2,900 people as part of a previously announced cost-cutting plan. CVS's stock rose $1.65 to $63.03 in early trading. Glenview CEO Larry Robbins was to meet with CVS Chief Executive Karen Lynch to present proposals to energize the company but not break it up. The gathering between CVS and Glenview comes after CVS's stock has fallen more than 22% this year as of Friday's close, while the S&P 500 has risen about 20%.
